Your browser doesn't support javascript.
loading
Prevalence of Self-Reported Venous Thromboembolism and Cardiovascular Risk Factors in Patients with Ulcerative Colitis: The GETAID FOCUS Study.
Guillo, Lucas; Amiot, Aurélien; Serrero, Mélanie; Altwegg, Romain; Roblin, Xavier; Atanasiu, Calina; Buisson, Anthony; Le Berre, Catherine; Reenaers, Catherine; Gornet, Jean-Marc; Laharie, David; Abitbol, Vered; Biron, Amélie; Caron, Bénédicte; Nancey, Stéphane; Chupin, Antoine; Blain, Antoine; Vuitton, Lucine; Caillo, Ludovic; Kirchgesner, Julien; Nachury, Maria; Peyrin-Biroulet, Laurent.
Afiliação
  • Guillo L; Department of Gastroenterology, University Hospital of Marseille Nord, University of Aix-Marseille, Chemin des Bourrely, 13015, Marseille, France. lucas.guillo690@gmail.com.
  • Amiot A; Department of Gastroenterology, Groupe Hospitalier Henri Mondor-Albert Chennevier, APHP, EC2M3-EA7375, University of Paris Est Créteil, Créteil, France.
  • Serrero M; Department of Gastroenterology, University Hospital of Marseille Nord, University of Aix-Marseille, Chemin des Bourrely, 13015, Marseille, France.
  • Altwegg R; Department of Gastroenterology, Saint-Eloi Hospital, University Hospital of Montpellier, Montpellier, France.
  • Roblin X; Department of Gastroenterology, Saint-Etienne University Hospital, Saint-Étienne, France.
  • Atanasiu C; Department of Gastroenterology, AP-HP, Hôpital Saint-Joseph, Paris, France.
  • Buisson A; Université Clermont Auvergne, 3iHP, CHU Clermont-Ferrand, Service d'Hépato-Gastroentérologie, Inserm U1071, M2iSH, USC-INRA 2018, Clermont-Ferrand, France.
  • Le Berre C; Department of Gastroenterology, Institut des Maladies de L'Appareil Digestif (IMAD), CIC Inserm 1413, Nantes University Hospital, Nantes, France.
  • Reenaers C; Department of Gastroenterology, University Hospital of Liège, Liège, Belgium.
  • Gornet JM; Assistance Publique - Hôpitaux de Paris, Hôpital Saint Louis, Université de Paris, Paris, France.
  • Laharie D; CHU de Bordeaux, Hôpital Haut-Lévêque, Service d'Hépato-gastroentérologie et oncologie digestive - Université de Bordeaux, 33000, Bordeaux, France.
  • Abitbol V; Department of Gastroenterology, Paris Descartes University, Sorbonne Paris Cité, Cochin Hospital, APHP, Paris, France.
  • Biron A; Department of Gastroenterology, Reims University Hospital, Reims, France.
  • Caron B; Department of Gastroenterology, Hautepierre Strasbourg University Hospital and INSERM U1113 IRFAC, University of Strasbourg, Strasbourg, France.
  • Nancey S; Department of Gastroenterology and Inserm U1111-CIRI, Lyon-Sud University Hospital, Hospices Civils de Lyon, Pierre Bénite, France.
  • Chupin A; Department of Gastroenterology, Hôpital de Bicêtre, Assistance Publique-Hôpitaux de Paris and Université Paris Saclay, Le Kremlin-Bicêtre, France.
  • Blain A; Department of Gastroenterology, Institut Mutualiste Montsouris, Paris, France.
  • Vuitton L; Department of Gastroenterology, Besancon University Hospital, Besançon, France.
  • Caillo L; Department of Gastroenterology, University Hospital of Nimes, Nîmes, France.
  • Kirchgesner J; Department of Gastroenterology, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP, Hôpital Saint-Antoine, Sorbonne Université, Paris, France.
  • Nachury M; Univ, Lille, Inserm, CHU Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, 59000, Lille, France.
  • Peyrin-Biroulet L; Department of Gastroenterology, Inserm NGERE U1256, University Hospital of Nancy, University of Lorraine, Vandoeuvre-lès-Nancy, France.
Dig Dis Sci ; 67(9): 4525-4532, 2022 09.
Article em En | MEDLINE | ID: mdl-35246801
ABSTRACT
BACKGROUND AND

AIMS:

Patients with inflammatory bowel disease have an increased risk of venous thromboembolism (VTE) and cardiovascular disease (CVD). The study aims to determine the prevalence of CVD and VTE risk factors in a large population of patients with ulcerative colitis (UC).

METHODS:

We conducted a cross-sectional study in 33 French and Belgium referral centers. A questionnaire was developed to explore self-reported risk factors for VTE and CVD, based on the latest international guidelines, in consecutive patients with UC.

RESULTS:

A total of 1071 patients with UC were included. There were 539 women (50.3%), and the median age of patients was 44 years [32; 57]. The median disease duration was 10 years [6; 17]. In the cohort, 36.5% of patients reported no cardiovascular risk factor (CVRF) and 72% had ≤ 1 CVRF. Regarding cardiovascular risk markers (CVRM) 36.9% of patients reported no CVRM and 78% had ≤ 1 CVRM. Of the 1071 patients, 91.3% of patients reported no VTE strong risk factor and 96% had ≤ 1 VTE moderate risk factor.

CONCLUSION:

This is the first cohort specifically designed to assess both VTE and CVD risks in patients with UC. More than one third of patients with UC had no CVRF and around three quarters had ≤ 1 CVRF. In addition, more than nine out of ten patients had no VTE strong risk factor and ≤ 1 moderate risk factor. Physicians should be aware of these factors in their patients.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Colite Ulcerativa / Tromboembolia Venosa Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prevalence_studies / Qualitative_research / Risk_factors_studies Limite: Adult / Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Colite Ulcerativa / Tromboembolia Venosa Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prevalence_studies / Qualitative_research / Risk_factors_studies Limite: Adult / Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article